COMPANY PRESENTATION

An International High-Growth Platform With a New Approach to Orthopaedics

DISCLAIMER

This presentation (the "Presentation") has been prepared by Medacta Group SA ("Medacta" and together with its subsidiaries, "we", "us" or the "Group"). The information contained in the Presentation does not purport to be comprehensive. Please refer to the financial reports available on our website athttps://www.medacta.com/EN/investors.

Forward-looking information

This Presentation has been prepared by Medacta and may include forward-looking information and statements concerning the outlook for our business. These statements are based on current expectations, estimates and projections about the factors that may affect our future performance. These expectations, estimates and projections are generally identifiable by statements containing words such as "expects", "believes", "estimates", "targets", "plans", "outlook" or similar expressions.

There are numerous risks and uncertainties, many of which are beyond our control, that could cause our actual results to differ materially from the forward-looking information and statements made in this Presentation. The important factors that could cause such differences include: changes in the global economic conditions and the economic conditions of the regions and markets in which the Group operates; changes in healthcare regulations (in particular with regard to medical devices); the development of our customer base; the competitive environment in which the Group operates; manufacturing or logistics disruptions; the impact of fluctuations in foreign exchange rates; and such other factors as may be discussed from time to time. Although we believe that our expectations reflected in any such forward-looking statement are based upon reasonable assumptions, we can give no assurance that those expectations will be achieved.

Alternative Performance Measures

This Presentation may contain information regarding alternative performance measures. Definitions of these measures and reconciliations between such measures and their IFRS counterparts if not defined in the Presentation may be found on the financial reports available on our website athttps://www.medacta.com/EN/investors.

THIS PRESENTATION IS NOT AN INVITATION TO PURCHASE SECURITIES OF MEDACTA OR THE GROUP

We are an international company specialized in the design, production and distribution of innovative orthopaedic products and accompanying surgical techniques for joint replacement, spine surgery and sports medicine.

Key Growth Factors

Revenue Generation

Large Ortho market with solid growth, driven by attractive industry fundamentals.

Continued product expansion of established Hip and Knee portfolio, as well as Shoulder, Spine and nascent Sports Med product lines.

Global and established presence including the US (largest Ortho Market),

Japan and Australia - with ample room to expand.

Commercial strategy focused on increasing penetration and sales force.

Constant product developments fostered by efficient R&D activity, continued collaboration with surgeons, adoption of cutting-edge technologies.

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

Disclaimer

Medacta Group SA published this content on 11 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 March 2021 15:23:06 UTC.